Camber Pharma Launches Generic Maxalt®
Piscataway, NJ, February 3, 2015– Camber Pharmaceuticals announces that it has launched Rizatriptan Benzoate 5mg and 10mg tablets. The drug is the generic version of Maxalt® tablets. Rizatriptan is used to treat migraine headaches.
Rizatriptan is available in an 18 count blister pack for both 5mg and 10mg.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year